Zeltia Group’s Yondelis Gets First OK for Ovarian Cancer in the Philippines; U.S. FDA Panel to Review Drug July 15

Reuters -- Spain's Zeltia said on Friday its Yondelis drug had been approved for the treatment of recurrent ovarian cancer in the Philippines, ahead of a hoped-for green light in the key U.S. market next week.